Risovalisib for PIK3CA-mutated recurrent or persistent ovarian clear cell carcinoma: a single-arm, multicentre, phase 2 trial

The Lancet Oncology · Elsevier

Аннотация

Publication date: Available online 10 November 2026 Source: The Lancet Oncology Author(s): Jiajia Li, Kan Yonemori, Kaoru Niimi, Satoshi Nakagawa, Kosuke Yoshihara, Shogo Shigeta, Jianqing Zhu, Hui Qiu, Jie Tang, Hidemichi Watari, Tatsuyuki Chiyoda, Shoji Nagao, Zhiqing Liang, Yuanguang Meng, Huimei Zhou, Ruifang An, Aikou Okamoto, Shin Nishio, Kazuhiro Takehara, Junzo Hamanishi

Читать у издателя →

Похожие статьи